摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cis-[Ti(isopropoxide)2((CH2N(CH3)CH2C6H2(CH3)2O)2)] | 914490-79-2

中文名称
——
中文别名
——
英文名称
cis-[Ti(isopropoxide)2((CH2N(CH3)CH2C6H2(CH3)2O)2)]
英文别名
[Ti((O(CH3)2C6H2CH2N(CH3)CH2)2)(OiPr)2];(6,6'-((ethane-1,2-diylbis(methylazanediyl))bis(methylene))bis(2,4-dimethyl-phenol))-diisopropoxide titanium(IV)
cis-[Ti(isopropoxide)2((CH2N(CH3)CH2C6H2(CH3)2O)2)]化学式
CAS
914490-79-2
化学式
C28H44N2O4Ti
mdl
——
分子量
520.548
InChiKey
IOHKLKJCGLYMQE-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.92
  • 重原子数:
    35.0
  • 可旋转键数:
    4.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    43.4
  • 氢给体数:
    0.0
  • 氢受体数:
    6.0

文献信息

  • Heptacoordinate Heteroleptic Salan (ONNO) and Thiosalan (OSSO) Titanium(IV) Complexes: Investigation of Stability and Cytotoxicity
    作者:Martin Grützke、Tiankun Zhao、Timo A. Immel、Thomas Huhn
    DOI:10.1021/acs.inorgchem.5b00690
    日期:2015.7.20
    heptacoordinate titanium(IV) complexes were synthesized based on the concept of hetero-bis-chelate stabilization of salan (ONNO) and thiosalan (OSSO) titanium(IV)alkoxides with 2,6-pyridinedicarboxylic acid (dipic) and derivatives thereof. The resulting compounds were investigated in a solid by X-ray diffraction and in solution by NMR spectroscopy. A thiosalan (OSSO) titanium(IV) complex could be isolated
    根据salan(ONNO)和thiOSalan(OSSO)(IV)烷氧基与2,6-吡啶甲酸(dipic)及其衍生物的异双螯合稳定概念,合成了七种七配位(IV)配合物。通过X射线衍射在固体中和通过NMR光谱在溶液中研究所得化合物。可以分离出一个代(OSSO)(IV)配合物,并通过1 H NMR光谱显示了其通过二元构象的构象稳定性,即使在室温下,也能导致无通量的行为。通过紫外可见监测的解研究(> 5 Mio),在pH 1.9、6.8和12.1下评估了选定配合物的稳定性。当量的。即使在pH 12.1时,[L 1 Ti(dipic)1 ]仍显示出t超过2天的1/2。在两种人类癌细胞系中研究了所有化合物的细胞毒性。除[L 4 Ti(dipic)1 ]外,所有测试的化合物均达到顺铂范围的IC 50值,事实证明该化合物无毒。因此,二斜肽的功能性被很好地耐受,并且既不影响杂合剂复合物的稳定性也没有细胞毒性。
  • Design, Synthesis, Computational, and Preclinical Evaluation of natTi/45Ti-Labeled Urea-Based Glutamate PSMA Ligand
    作者:Kristina Søborg Pedersen、Christina Baun、Karin Michaelsen Nielsen、Helge Thisgaard、Andreas Ingemann Jensen、Fedor Zhuravlev
    DOI:10.3390/molecules25051104
    日期:——

    Despite promising anti-cancer properties in vitro, all titanium-based pharmaceuticals have failed in vivo. Likewise, no target-specific positron emission tomography (PET) tracer based on the radionuclide 45Ti has been developed, notwithstanding its excellent PET imaging properties. In this contribution, we present liquid–liquid extraction (LLE) in flow-based recovery and the purification of 45Ti, computer-aided design, and the synthesis of a salan-natTi/45Ti-chelidamic acid (CA)-prostate-specific membrane antigen (PSMA) ligand containing the Glu-urea-Lys pharmacophore. The compound showed compromised serum stability, however, no visible PET signal from the PC3+ tumor was seen, while the ex vivo biodistribution measured the tumor accumulation at 1.1% ID/g. The in vivo instability was rationalized in terms of competitive citrate binding followed by Fe(III) transchelation. The strategy to improve the in vivo stability by implementing a unimolecular ligand design is presented.

    尽管基制药在体外表现出有希望的抗癌特性,但所有基于的制药品在体内均失败。同样地,尽管45Ti放射性核素具有出色的PET成像特性,但尚未开发出基于其的靶向特异性正电子发射断层扫描(PET)示踪剂。在本文中,我们介绍了基于流动液-液萃取(LLE)的45Ti回收和纯化、计算机辅助设计以及合成含有Glu-urea-Lys药效团的salan-natTi/45Ti-chelidamic acid(CA)-前列腺特异性膜抗原(PSMA)配体。该化合物显示出受到血清稳定性的影响,然而,未观察到来自PC3+肿瘤的PET信号,而外体分布测量显示肿瘤积累为1.1% ID/g。体内不稳定性是通过竞争性柠檬酸结合,随后是Fe(III)跨螯合来解释的。本文介绍了通过实施单分子配体设计来提高体内稳定性的策略。
  • Active Cytotoxic Reagents Based on Non-metallocene Non-diketonato Well-Defined <i>C</i><sub>2</sub>-Symmetrical Titanium Complexes of Tetradentate Bis(phenolato) Ligands
    作者:Michal Shavit、Dani Peri、Cesar M. Manna、Jacob S. Alexander、Edit Y. Tshuva
    DOI:10.1021/ja0753086
    日期:2007.10.1
    of non-Cp-based non-diketonato-based C2-symmetrical octahedral Ti(IV) complexes of dianionic diamine bis(phenolato) ligands, which are conveniently obtained as single isomers in quantitative yields, leads to appreciable cytotoxicity against colon and ovarian cells with a non-transferrin-dependent cell penetration mechanism. The ligand structural features including steric demands, symmetry, and aromaticity
    一类新的基于非 Cp 的非二酮基 C2 对称八面体 Ti(IV)配合物的双阴离子二胺双(苯酚配体,它们可以作为单一异构体以定量产率方便地获得,对结肠和结肠产生可观的细胞毒性。具有非转铁蛋白依赖性细胞渗透机制的卵巢细胞。配体结构特征(包括空间需求、对称性和芳香性)强烈影响活性,支持其在生物作用机制中的作用。
  • Facile synthesis of [ONON] type titanium(IV) bis-chelated complexes in alcoholic solvents and evaluation of anti-tumor activity
    作者:Tiankun Zhao、Peng Wang、Nan Liu、Shanjia Li、Mingjun Yang、Zhongduo Yang
    DOI:10.1016/j.jinorgbio.2022.111925
    日期:2022.10
    Most [ONON] type Ti(IV) complexes exhibit selectively enhanced inhibition activity against Hep G2 cells in comparison with Salan Ti(IV) complexes. Among which, the inhibitory activity of 2 t (IC50: 0.15 ± 0.1 μM) against Hep G2 cells is about 80 times enhanced than that of cisplatin (IC50: 12.4 ± 1.2 μM). The [ONON] type Ti(IV) complexes slowly released nontoxic phenolato ligands in presence of large
    通过使用正丙醇作为溶剂并使用 H 2 O 进行分离的高效方案,合成了由 2,6-吡啶羧酸稳定的新型抗肿瘤二基-双-(苯酚)[ONON] 型(IV)配合物。总共合成了 20 种 [ONON] 型和 2 种 Salan Ti (IV)双螯合配合物,产率从 68% 到 96%。使用 Ti(O i Pr) 4或 TiCl 4作为起始材料,所有反应都可以在 80 °C 的 1.5 分钟内完成。与 Salan Ti 相比,大多数 [ONON] 型 Ti (IV)复合物对 Hep G2 细胞表现出选择性增强的抑制活性 (四)配合物。其中,2t (IC 50 : 0.15 ± 0.1 μM)对Hep G2细胞的抑制活性比 顺铂( IC 50 : 12.4 ± 1.2 μM)增强约80倍。[ONON] 型 Ti (IV)配合物在存在大量性介质的情况下缓慢释放无毒的配体,并且基于属摄取分析提出了这些
  • Synthesis and X-ray structure analysis of a heptacoordinate titanium(iv)-bis-chelate with enhanced in vivo antitumor efficacy
    作者:Timo A. Immel、Martin Grützke、Anne-Katrin Späte、Ulrich Groth、Peter Öhlschläger、Thomas Huhn
    DOI:10.1039/c2cc31624b
    日期:——
    Chelate stabilization of a titanium(IV)-salan alkoxide by ligand exchange with 2,6-pyridinedicarboxylic acid (dipic) resulted in heptacoordinate complex 3 which is not redox-active, stable on silica gel and has increased aqueous stability. 3 is highly toxic in HeLa S3 and Hep G2 and has enhanced antitumor efficacy in a mouse cervical-cancer model.
    通过与2,6-吡啶羧酸(二甲基)进行配体交换而使(IV)-烷氧基烷氧基化物的螯合稳定化导致七配位络合物3,其不具有氧化还原活性,在硅胶上稳定并且具有增加的稳定性。3在HeLa S3和Hep G2中具有高毒性,并且在小鼠宫颈癌模型中具有增强的抗肿瘤功效。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫